Résultats de la recherche - Rebecca Modiste
- Résultat(s) 1 - 3 résultats de 3
-
1
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia par Yana Pikman, Gabriela Alexe, Giovanni Roti, Amy Saur Conway, Andrew Furman, Emily S. Lee, Andrew E. Place, Sunkyu Kim, Chitra Saran, Rebecca Modiste, David M. Weinstock, Marian H. Harris, Andrew L. Kung, Lewis B. Silverman, Kimberly Stegmaier
Publié 2016Artigo -
2
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents par Chen Lossos, Yunpeng Liu, Kellie E. Kolb, Amanda L. Christie, Alexandria Van Scoyk, Sanjay M. Prakadan, Kay Shigemori, Kristen E. Stevenson, Sara Morrow, Olivia D. Plana, Cameron Fraser, Kristen L. Jones, Huiyun Liu, Christian P. Pallasch, Rebecca Modiste, Quang‐Dé Nguyen, Jeffrey W. Craig, Elizabeth A. Morgan, Francisco Vega, Jon C. Aster, Kristopher A. Sarosiek, Alex K. Shalek, Michael T. Hemann, David M. Weinstock
Publié 2019Artigo -
3
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer par Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge, Rhamy Zeid, Isaac S. Harris, Bojana Jovanović, Katherine Murphy, Binbin Wang, Xintao Qiu, Jennifer E. Endress, Jaime M. Reyes, Klothilda Lim, Alba Font‐Tello, Sudeepa Syamala, Tengfei Xiao, Chandra Sekhar Reddy Chilamakuri, Evangelia K. Papachristou, Clive S. D’Santos, Jayati Anand, Kunihiko Hinohara, Wei Li, Thomas O. McDonald, Adrienne Luoma, Rebecca Modiste, Quang‐Dé Nguyen, Brittany C. Michel, Paloma Cejas, Cigall Kadoch, Jacob D. Jaffe, Kai W. Wucherpfennig, Jun Qi, X. Shirley Liu, Henry W. Long, Myles Brown, Jason S. Carroll, Joan S. Brugge, James E. Bradner, Franziska Michor, Kornélia Polyák
Publié 2020Artigo
Outils de recherche:
Sujets similaires
Biology
Cancer research
Cancer
Computational biology
Gene
Medicine
Pharmacology
BET inhibitor
BRD4
Biochemistry
Breast cancer
Bromodomain
CRISPR
Cell cycle
Chemistry
Chromatin
Cyclin-dependent kinase
Cyclin-dependent kinase 6
DNA repair
Epigenetics
Genetics
Histone
Histone deacetylase
Immunology
Internal medicine
Lymphoma
Romidepsin
Synthetic lethality
Triple-negative breast cancer